CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Ceribell, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$26.00+0.96 (+3.83%)
Close on Oct 19, 2026
- Market cap
- $988.83M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$13.29 (+104.6%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Ceribell, Inc. grew revenue 31.7% to $101.96M over the twelve months to Jun 30, 2026. Free cash flow was -$54.72M.
Revenue
$101.96M
+31.7% vs. a year earlier
Operating income
-$69.97M
TTM Q2 2026
Free cash flow
-$54.72M
TTM Q2 2026
EPS, diluted
-$1.76
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $988.83M
- P/E ratio
- –
- Price to sales
- 9.70
- Price to book
- 7.71
- Dividend yield
- –
- Free cash flow yield
- -5.53%
Fundamentals
- Revenue
- $101.96M
- Net income
- -$66.00M
- EPS, diluted
- -$1.76
- Free cash flow
- -$54.72M
- Book value per share
- $3.37
- Diluted shares
- 38M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$101.96M+31.7% YoY
Gross profit
$90.65M+33.4% YoY
Operating income
-$69.97M
Net income
-$66.00M
EPS, diluted
-$1.76
Free cash flow
-$54.72M
Reported periodTrailing twelve months